Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Usefulness of 99mTc MAG3 renogram for monitoring before and after carbon ion radiotherapy in patients with renal cell carcinoma

Ryuichi Nishii, Kana Yamazaki, Goro Kasuya, Hirokazu Makishima, Tachen Chang, Kentaro Tamura, Hiroshi Tsuji and Tatsuya Higashi
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1161;
Ryuichi Nishii
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kana Yamazaki
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Goro Kasuya
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirokazu Makishima
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tachen Chang
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kentaro Tamura
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Tsuji
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsuya Higashi
1National Institute of Radiological Sciences (NIRS), QST Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1161

Introduction: Carbon‐ion radiotherapy (CIRT) for primary renal cell carcinoma (RCC) showed high local control rates (100% at 5 years) even in the inoperable patients. For clinical management after CIRT in RCC patients, evaluation of preserved renal function especially in non-irradiated renal parenchyma is important to assess and monitor the adverse event of renal function. Monitoring using eGFR is convenient and useful after CIRT in RCC, however, it is hard to evaluate the split function of the kidneys. It has been suggested that serial assessment of renal function by measuring tubular extraction with 99mTc-MAG3 might permit earlier and more sensitive detection of renal damage. <Patients> A total of 6 patients who had received CIRT for RCC; 3 patients for 66.0Gy/12Fractions and 3 patients for 72.0Gy/12Fractions were enrolled in this study. 99mTc-MAG3 renogram before, 3-6 months and 12-18 months after CIRT were analyzed. The effective renal plasma flow of both kidneys (total cERPF), peak time (min), T1/2 from the PT (min), C20/max index were calculated and were compared with their eGFR and the adverse events evaluation category of National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 <Result and Summary> In the analysis using 99mTc-MAG3 renogram, it was possible to detect the renal function deterioration of non-irradiated renal parenchyma. In some patients, the 99mTc-MAG3 renogram showed renal function deterioration, which it might be not due to CIRT but systemic diseases or kidney diseases. 99mTc-MAG3 renogram is considered to be a useful diagnostic tool for the assessment of split renal function in CIRT for RCC. <Teaching Points> 1) 99mTc-MAG3 renogram is a useful non-invasive diagnostic tool to evaluate renal function after CIRT in patients with renal cell carcinoma, especially for the assessment of split renal function.2) With the 99mTc-MAG3 renogram, it is possible to detect renal function deterioration of non-irradiated renal parenchyma.3) Serial assessment of renal function by measuring tubular extraction with 99mTc-MAG3 might permit earlier and more sensitive detection of renal damage after CIRT.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Usefulness of 99mTc MAG3 renogram for monitoring before and after carbon ion radiotherapy in patients with renal cell carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Usefulness of 99mTc MAG3 renogram for monitoring before and after carbon ion radiotherapy in patients with renal cell carcinoma
Ryuichi Nishii, Kana Yamazaki, Goro Kasuya, Hirokazu Makishima, Tachen Chang, Kentaro Tamura, Hiroshi Tsuji, Tatsuya Higashi
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1161;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Usefulness of 99mTc MAG3 renogram for monitoring before and after carbon ion radiotherapy in patients with renal cell carcinoma
Ryuichi Nishii, Kana Yamazaki, Goro Kasuya, Hirokazu Makishima, Tachen Chang, Kentaro Tamura, Hiroshi Tsuji, Tatsuya Higashi
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1161;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Reduction of injected activity for MBF with a CZT Cardiac SPECT Camera
Show more

Educational Exhibits Poster Session I

  • FDG-PET/CT as the superior imaging modality for inflammatory bowel disease
  • Total-Body NaF-PET/CT and its Implications for Osteoporosis
  • The Role of F18-FDG PETCT in the Evaluation and Surveillance of Rosai-Dorfman Disease
Show more Educational Exhibits Poster Session I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire